Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details) - Schedule of options granted to employees and non-employees outstanding

v3.22.2.2
Stock-Based Compensation (Details) - Schedule of options granted to employees and non-employees outstanding
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Schedule of options granted to employees and non-employees outstanding [Abstract]  
Options, Outstanding at Beginning (in Shares) | shares 2,577,335
Weighted Average Exercise Price, Outstanding at Beginning Balance $ 0.23
Total Weighted Average Intrinsic Value, Outstanding at Beginning Balance $ 0.06
Remaining Life, Outstanding at Beginning Balance 5 years 5 months 1 day
Options, Granted (in Shares) | shares
Weighted Average Exercise Price, Granted
Total Weighted Average Intrinsic Value, Granted
Remaining Life, Granted
Options, Exercised/Expired/Forfeited (in Shares) | shares (44,779)
Weighted Average Exercise Price, Exercised/Expired/Forfeited $ (0.06)
Total Weighted Average Intrinsic Value, Exercised/Expired/Forfeited
Remaining Life, Exercised/Expired/Forfeited
Options, Outstanding at ending (in Shares) | shares 2,532,556
Weighted Average Exercise Price, Outstanding at ending $ 0.23
Total Weighted Average Intrinsic Value, Outstanding at ending $ 0.06
Remaining Life, Outstanding at ending 5 years 5 months 1 day
Options, Exercisable (in Shares) | shares 2,345,230
Weighted Average Exercise Price, Exercisable $ 0.23
Total Weighted Average Intrinsic Value, Exercisable $ 0.06
Remaining Life, Exercisable 4 years 6 months 10 days
Options, Expected to be vested (in Shares) | shares 187,326
Weighted Average Exercise Price, Expected to be vested $ 0.29
Total Weighted Average Intrinsic Value, Expected to be vested $ 0
Remaining Life, Expected to be vested 8 years 4 months 20 days